WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit

West Pharmaceutical Services, Inc. (WST) delivered adjusted first-quarter 2025 earnings per share (EPS) of $1.45, which declined 7.1% year over year. The figure, however, topped the Zacks Consensus Estimate by 18.9%.The adjustments include expenses related to the amortization of acquisition-related intangible assets, among others.GAAP EPS for the quarter was $1.23, reflecting a decline of 20.6% from the year-ago figure. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)WST’s Revenues ...